William Sharbaugh
Chief Operating Officer bei Jaguar Holding Company II
Profil
Herr William J. Sharbaugh ist Chief Operating Officer bei PPD, Inc. und Chief Operating Officer bei Pharmaceutical Product Development LLC, Chief Operating Officer bei Eagle Holding Company II LLC und Chief Operating Officer bei Jaguar Holding Company II. Er ist Mitglied des Board of Directors bei Wildcat Acquisition Holdings (UK) Ltd. Herr Sharbaugh war zuvor als Chief Operating Officer bei Pharmaceutical Product Development LLC, als Vice President-Global Development Operations bei Bristol Myers Squibb Co. und als Principal bei Merck & Co. beschäftigt. Er war auch im Vorstand von Clinical Research Advantage, Inc. Er erhielt seinen Bachelor-Abschluss von der US Military Academy, einen Abschluss von der Wharton School der University of Pennsylvania, einen Abschluss von der Temple University School of Pharmacy und einen Abschluss von der Boston University.
Aktive Positionen von William Sharbaugh
| Unternehmen | Position | Beginn |
|---|---|---|
Jaguar Holding Company II
 Jaguar Holding Company II Medical SpecialtiesHealth Technology Jaguar Holding Co. II operates as a holding company. The company is headquartered in Wilmington, NC. | Chief Operating Officer | - |
Eagle Holding Company II LLC
 Eagle Holding Company II LLC Miscellaneous Commercial ServicesCommercial Services Eagle Holding Company II LLC operates as a holding company which engages in the provision of clinical development, post-approval, and laboratory services. The company is headquartered in Wilmington, NC. | Chief Operating Officer | - |
Wildcat Acquisition Holdings (UK) Ltd.
 Wildcat Acquisition Holdings (UK) Ltd. Financial ConglomeratesFinance Wildcat Acquisition Holdings (UK) Ltd. is an investment holding British company founded in 2011. The company is based in Cambridge, UK. | Director/Board Member | 05.12.2011 |
Ehemalige bekannte Positionen von William Sharbaugh
| Unternehmen | Position | Ende |
|---|---|---|
| PPD, INC. | Chief Operating Officer | 08.12.2021 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.01.2007 |
Clinical Research Advantage, Inc.
 Clinical Research Advantage, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Research Advantage, Inc. provides research services to the pharmaceutical companies and clinical research organizations. The company was founded in 1992 and is headquartered in Tempe, AZ. | Director/Board Member | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Pharmaceutical Product Development LLC
 Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | Chief Operating Officer | - |
Ausbildung von William Sharbaugh
| Boston University | Graduate Degree |
| US Military Academy | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Graduate Degree |
| Temple University School of Pharmacy | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | Commercial Services |
Clinical Research Advantage, Inc.
Clinical Research Advantage, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Research Advantage, Inc. provides research services to the pharmaceutical companies and clinical research organizations. The company was founded in 1992 and is headquartered in Tempe, AZ. | Commercial Services |
Jaguar Holding Company II
Jaguar Holding Company II Medical SpecialtiesHealth Technology Jaguar Holding Co. II operates as a holding company. The company is headquartered in Wilmington, NC. | Health Technology |
Eagle Holding Company II LLC
Eagle Holding Company II LLC Miscellaneous Commercial ServicesCommercial Services Eagle Holding Company II LLC operates as a holding company which engages in the provision of clinical development, post-approval, and laboratory services. The company is headquartered in Wilmington, NC. | Commercial Services |
PPD, Inc.
 PPD, Inc. Miscellaneous Commercial ServicesCommercial Services PPD, Inc. engages in the provision of drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. It operates through the Clinical Development Services and Laboratory Services segments. The Clinical Development Services segment focuses in early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment comprises of bioanalytical, vaccine sciences, GMP, central lab and biomarker testing. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC. | Commercial Services |
Wildcat Acquisition Holdings (UK) Ltd.
Wildcat Acquisition Holdings (UK) Ltd. Financial ConglomeratesFinance Wildcat Acquisition Holdings (UK) Ltd. is an investment holding British company founded in 2011. The company is based in Cambridge, UK. | Finance |
